Sotio Biotech Ag

This early-phase study tested a new drug called SO-C101, either by itself or combined with the immunotherapy pembrolizumab, in 115 people with various advanced solid tumors (like lung, kidney, or skin cancer) that had stopped responding to standard treatments. The main goals were…